"Insulin-Pump Use Benefits Young People With Type 1 Diabetes" - Miriam E. Tucker
– October 10, 2017 ––
Use of insulin pumps is associated with better glycemic control and lower rates of severe hypoglycemia and diabetic ketoacidosis compared with multiple daily injections among youth with type 1 diabetes, new research shows. The findings, from a large European database, were published in the Journal of the American Medical Association. Demonstrating that insulin pumps are safe and effective is important because they are one of the core components of "artificial-pancreas" technology, the authors point out. Ronald Tamler, MD, associate professor of medicine, endocrinology, diabetes and bone disease at the Icahn School of Medicine at Mount Sinai and director of the Mount Sinai Clinical Diabetes Institute, who was not involved in the study, said it “highlights the great progress the technology has made, we at Mount Sinai use insulin-pump therapy – with or without continuous glucose monitoring – for many of our patients with type 1 diabetes.” However, Dr. Tamler also cautioned it’s not for everyone.
- Ronald Tamler, MD, Associate Professor, Medicine, Endocrinology, Diabetes and Bone Disease, Icahn School of Medicine at Mount Sinai, Director, Mount Sinai Clinical Diabetes Institute